Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

15. November 2021 07:00 ET | Quelle: Emergex Vaccines Holding Ltd

Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate

PRESS RELEASE Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate Synthetic vaccine designed to prime T-Cells to rapidly remove...
15. November 2021 02:00 ET | Quelle: Emergex Vaccines Holding Ltd

Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate

PRESS RELEASE Emergex announces approval to initiate Phase I clinical trial of its next generation COVID-19 vaccine candidate Synthetic vaccine designed to prime T-Cells to rapidly remove...